Vildagliptin
Therapeutic Category
- Anti-diabetic
Innovator Brand
GMP
DMF
Filed
Under Filing
Sample
Indication
Vildagliptin, known under the brandname of Galvus, Zavamet, is an oral anti-hyperglycemic agent (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of Glucagon-like peptide-1(GLP-1) and Glucose-dependent insulinotropic polypeptide(GIP) by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas.
Vildagliptin has been shown to reduce hyperglycemia in type 2 diabetes mellitus.
CTX Lifesciences, is one of the leading Active Pharmaceutical Ingredients ( API ) manufacturer and supplier globally for Vildagliptin with CAS Number: 274901-16-5 . We are a leading exporter of Vildagliptin with CAS Number: 274901-16-5. We are a trusted supplier with API exports in more than 87 Countries including the US, Europe, Brazil, Latin America, China, Korea,Iran, Middle East and other emerging markets.
CTX Lifesciences is one of the leading API manufacturer & supplier of Vildagliptin with CAS Number: 274901-16-5 . This product is provided from our GMP compliant plant with product made under complete cGMP conditions. We provided with documentation support Drug Master File ( DMF ). Our manufacturing plant at Surat,India has accreditation by US-FDA, EDQM, EMA, ANVISA, KFDA, MOH-IRAN, Health Canada & Russian Authorities.
CTX also offers other Dipeptidyl peptidase-4( DDP-4 ) inhibitor as mentioned below. Please check them out below.
Disclaimer: CTX Lifesciences respects patent laws and conventions of pharmaceuticals as applicable in different countries.
API/Substances covered by patent are not offered to the countries where the patent law is in force. However, the final responsibility lies with the customer.